BCL2 and renal carcinoma: Using real-time PCR, we found that inhibition of GSK-3 resulted in a marked reduction in the expression of NF-κB target genes Bcl-2 and XIAP, suggesting a downregulation of NF-κB transcriptional activity in renal cancer cells (Figure 4B and C).